MedPath

Pituitary hormone profile after Brain Injury

Not Applicable
Conditions
Health Condition 1: S069- Unspecified intracranial injury
Registration Number
CTRI/2022/07/044009
Lead Sponsor
Indian Council of Medical Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Age 3 month to 16 years

2. Hospitalized for a clinical indication like altered sensorium, seizures, amnesia, repeated vomiting, bleeding nose or Ear, skull fracture, or neurological signs after traumatic brain injury

Exclusion Criteria

1. Patients who succumb within first 48 hours of hospitalization

2. Patients with pre-existing endocrinal disorder unrelated to existing illness

3. Patients with previously diagnosed static or progressive central nervous system disease (like epilepsy, brain tumor, meningoencephalitis, cerebral palsy)

4. Patients with history of consumption of drugs in the last 12 months which can affect interpretation of pituitary hormone levels (example corticosteroids, anti-epileptic drugs)

5. Patients with any major congenital anomalies (example neural tube defects) or chromosomal disorders

6. Patients who discontinue treatment before discharge

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of pituitary disorders in children with traumatic brain injuryTimepoint: Baseline, 6 months, 12 months, 24 months
Secondary Outcome Measures
NameTimeMethod
a.Association of pituitary dysfunction with the injury characteristics (severity, type, mechanism) <br/ ><br>b.Association of pituitary dysfunction with neuronal injury biomarkers <br/ ><br>c.Resolution of pituitary dysfunction in diagnosed cases during the study period <br/ ><br>Timepoint: 6, 12 and 24 months
© Copyright 2025. All Rights Reserved by MedPath